Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa.

Bionghi, Neda.Daftary, Amrita.Maharaj, Bhavna.Msibi, Zama Princess N.Rivet Amico, K.Friedland, Gerald H.Orrell, Catherine.Padayatchi, Nesri.O'Donnell, Max Roe.2019-12-152019-12-1520182018Bionghi, N., Daftary, A., Maharaj, B., Msibi, Z., Amico, K.R., Friedland, G., Orrell, C., Padayatchi, N. and O’Donnell, M.R. 2018. Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa. BMC Infectious Diseases 18(1), 171.http://dx.doi.org/10.1186/s12879-018-3080-2https://researchspace.ukzn.ac.za/handle/10413/16659CAPRISA, 2018.Abstract available in pdf.enElectronic pillbox.Drug-resistant tuberculosis.HIV.Bedaquiline.Real-time monitoring.Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa.Article